The promise and perils of stem cell therapeutics

140Citations
Citations of this article
285Readers
Mendeley users who have this article in their library.

Abstract

Stem cells are the seeds of tissue repair and regeneration and a promising source for novel therapies. However, apart from hematopoietic stem cell (HSC) transplantation, essentially all other stem cell treatments remain experimental. High hopes have inspired numerous clinical trials, but it has been difficult to obtain unequivocal evidence for robust clinical benefit. In recent years, unproven therapies have been widely practiced outside the standard clinical trial network, threatening the cause of legitimate clinical investigation. Numerous challenges and technical barriers must be overcome before novel stem cell therapies can achieve meaningful clinical impact. ©2012 Elsevier Inc.

Cite

CITATION STYLE

APA

Daley, G. Q. (2012, June 14). The promise and perils of stem cell therapeutics. Cell Stem Cell. https://doi.org/10.1016/j.stem.2012.05.010

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free